Unjha Formulations (BOM:531762) Other Current Payables: ₹0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531762 Unjha Formulations Ltd BOM:531762
74 GF Score
Price ₹25.50
GF Value ₹22.81
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Unjha Formulations Other Current Payables?

Unjha Formulations BOM:531762 -3.77% 74 Other Current Payables is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:531762 with a GF Score™ of 74/100 and a GF Value™ of ₹22.81 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Unjha Formulations's Other Current Payables for the quarter that ended in Jun. 2026 was ₹0.0 Mil.

Unjha Formulations's quarterly Other Current Payables increased from Dec. 2025 (₹0.0 Mil) to Mar. 2026 (₹0.6 Mil) but then declined from Mar. 2026 (₹0.6 Mil) to Jun. 2026 (₹0.0 Mil).

Unjha Formulations's annual Other Current Payables increased from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹0.6 Mil) and increased from Mar. 2025 (₹0.6 Mil) to Mar. 2026 (₹0.6 Mil).

Unjha Formulations Other Current Payables Related Terms

Unjha Formulations Other Current Payables Historical Data

* Premium members only.

The historical data trend for Unjha Formulations's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unjha Formulations Other Current Payables Chart

Unjha Formulations Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.56 0.59

Unjha Formulations Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.59 0.00
BOM:531762
74GF Score
Unjha Formulations Ltd BOM:531762
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unjha Formulations Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₹0.0 Mil mean?
Unjha Formulations (BOM:531762) has a Other Current Payables of ₹0.0 Mil as of Jun. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Unjha Formulations and its competitors.
Is Unjha Formulations' Other Current Payables too high?
Unjha Formulations' current Other Current Payables is ₹0.0 Mil. Overall, Unjha Formulations has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Unjha Formulations' Other Current Payables compare to ZTS?
Unjha Formulations' Other Current Payables of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Unjha Formulations and its competitors. Unjha Formulations's current Other Current Payables is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unjha Formulations stock overvalued right now?
Based on GuruFocus' analysis, Unjha Formulations (BOM:531762) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹22.81, compared to a current price of ₹25.50 — trading 11.8% above its estimated fair value. The current Other Current Payables is ₹0.0 Mil. Unjha Formulations' overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Unjha Formulations (BOM:531762), the current Other Current Payables is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unjha Formulations (BOM:531762) Overvalued in 2026?

Based on GuruFocus' analysis, Unjha Formulations stock appears to be overvalued. The current stock price of ₹25.50 is trading 11.8% above its estimated GF Value™ of ₹22.81. GuruFocus considers Unjha Formulations to be Modestly Overvalued.

Key valuation signals for BOM:531762:

  • Other Current Payables: ₹0.0 Mil
  • GF Value™: ₹22.81 vs. price of ₹25.50 (11.8% above fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the BOM:531762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unjha Formulations Business Description

Address Khali Char Rasta, State Highway, Sidhpur, Khali, Patan, GJ, IND, 384151
Unjha Formulations Ltd is an India-based manufacturer and exporter of Ayurvedic products. The company products include Isabgol powder under the Fibron and Fibron SF name, and Sat-Isabgol and Isabgol Husk. It also offers human and veterinary medicines.
74GF Score

Get the complete analysis for BOM:531762

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹25.50
Price
₹22.81
GF Value